Recruiting NA INTERVENTIONAL 1-arm NCT06880198

Study to Evaluate Impact® as Support to Anti PD1 or Anti PD1 Based Regimen Treatment in Patients With Inoperable Locally Advanced or Metastatic Melanoma (MELA-IMPACT)

An Interventional, Not Pharmacological Study to Evaluate Impact® as Support to Anti PD1 or Anti PD1 Based Regimen Treatment in Patients With Inoperable Locally Advanced or Metastatic Melanoma

Sponsor: Fondazione Melanoma Onlus

Conditions Locally Advanced Melanoma Melanoma Metastatic

Interventions Oral Impact®

Updated 2 times since 2025 Last updated: Sep 11, 2025 Started: Aug 1, 2024 Primary completion: Jul 31, 2027 Completion: Jul 31, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Locally Advanced Melanoma and Melanoma Metastatic, this trial is actively recruiting participants. The trial is conducted by Fondazione Melanoma Onlus and has accumulated 2 data snapshots since 2024. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

2 versions recorded

Oct 2025 — Present [monthly]

Recruiting NA
Apr 2025 — Oct 2025 [monthly]

Recruiting NA

First recorded

Aug 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fondazione Melanoma Onlus

Data source: Fondazione Melanoma Onlus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Napoli, Italy